Latest updates for Drug Discovery.

Fresh curated links around Drug discovery. are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Drug discovery Is changing. Drug development must change too.
  • Peptris is using AI to find drug candidates to shorten the time it takes for laboratory validation
  • Blue Light Breakthrough Could Speed Up Drug Discovery

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

newscientist.com /1 month ago

Drug discovery Is changing. Drug development must change too.

In this New Scientist CoLab podcast, experts from global life sciences leader Cytiva explain the hidden, high-stakes science of purification that is required to close the gap betwe...

Read source
yourstory.com /1 month ago

Peptris is using AI to find drug candidates to shorten the time it takes for laboratory validation

The Bengaluru-based company builds models that generate molecules and predict how they will behave, and has licensed its lead candidate to a US developer.

Read source
scitechdaily.com /1 month ago

Blue Light Breakthrough Could Speed Up Drug Discovery

Researchers have developed a visible-light-driven method that could help chemists build more complex drug-like molecules in fewer steps. A blue light commonly used in aquariums and...

Read source
pharmexec.com /2 weeks ago

<![CDATA[The Path from Discovery to Global Commercialization]]>

Read source
genengnews.com /1 month ago

Genome Mining Points to Less Toxic, More Potent Polyene Antifungals in Mice

The researchers identified Nys34 as a leading candidate after it demonstrated three-to-eightfold lower toxicity than amphotericin B in multiple human cell lines and reduced fungal...

Read source
genengnews.com /1 month ago

Receptor.AI and Sethera Plan to Create Closed-Loop Discovery and Optimization Workflow for Difficult Therapeutic Targets

The collaboration is specifically focused on applying Receptor.AI's computational platform to Sethera's proprietary polymacrocyclic peptide chemistry, encoded screening data, and r...

Read source
genengnews.com /1 month ago

Elix and University of Vienna Aim to Advance Drug Discovery Using AI

Elix and the University of Vienna will partner to bridge the gap between advanced structural biology and artificial intelligence. By integrating AI’s predictive power with experime...

Read source
journals.plos.org /6 days ago

A unified framework for potency-oriented AMP discovery via multi-modal learning and guided sequence synthesis

by Wenyu Zhang, Yizheng Wang, Yixiao Zhai, Pinglu Zhang, Yijie Ding, Quan Zou The rapid emergence of drug-resistant pathogens poses a critical threat to global health. With tradit...

Read source
bioengineer.org /1 month ago

Discovery Paves Way for Drug Therapies for Hypopigmentation Conditions

Ampyrone—an NSAID-related compound—has emerged as a promising way to enhance melanin production in human skin, according to a preclinical study led by Weill Cornell Medicine and Na...

Read source
e27.co /3 weeks ago

AI is not the beginning of drug discovery — it is the accelerator

Artificial intelligence is often framed as the technology that suddenly changed drug discovery. But that narrative misses an important truth: computational, or in silico, drug disc...

Read source
biopharmadive.com /1 month ago

With $263M, LifeMine unearths a new drug for organ transplants

Led by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplante...

Read source
genengnews.com /2 weeks ago

Rznomics Joins Lilly Gateway Labs to Quicken RNA Therapeutic Candidate Discovery and Development

Through its entry into Lilly Gateway Labs, Rznomics officials say they plan to accelerate candidate discovery and development across its target gene database bank comprising over 2...

Read source
asiatimes.com /2 weeks ago

Software firm designed medicines, overcoming skull’s limitations

Anthropic has just published the results of a protein design campaign. Fifteen targets, a written brief and an instruction to design small proteins that latch onto them. The model...

Read source
pharmexec.com /1 week ago

<![CDATA[The Full Path of Drug Development, and Why So Few Drugs Make It: Q&A with Dr. Ying Huang]]>

Read source
pharmexec.com /3 weeks ago

<![CDATA[Finding the Universal Truth in a Drug's Story]]>

Read source
genengnews.com /2 weeks ago

Centrix and University of Sussex Collaborate to Drive Data-Driven Pharma Development

The KTP provides access to academic expertise while embedding that capability within Centrix’s business. This project represents an opportunity to apply advanced data science techn...

Read source
genengnews.com /1 month ago

Novel Molecular Glue Discovery Platform Unlocks Undruggable Cancer Targets

A scalable platform to discover molecular glue degraders has been developed, identifying the first metabolically activated glue. The approach expands protein degradation targets, e...

Read source
thequantuminsider.com /1 week ago

Researchers Use IBM Quantum Computer to Test Drug-Docking Method

Insider Brief A team of Singapore-based researchers reports that a hybrid quantum-classical method could offer a new route to studying drug candidates using today’s Noisy Intermedi...

Read source
bioengineer.org /1 month ago

Insilico Medicine, Bora Pharmaceuticals partner on AI drug discovery and development

Insilico Medicine, a clinical-stage generative AI drug discovery company, has announced a multi-target strategic alliance with Bora Pharmaceuticals, a global pharmaceutical manufac...

Read source
bioengineer.org /1 day ago

Breaking down LSD to unlock new therapeutic discoveries

In a result that is already sending ripples through the fields of neuroscience and drug design, chemists at the University of California, Davis have performed something akin to a m...

Read source
aacr.org /1 month ago

Inaugural AACR D3 Opens With Insights From Leaders Across Drug Discovery and Development

During the opening session of the AACR Conference on Drug Discovery and Development, the conference cochairs—Patricia M. LoRusso, DO, PhD (hc), FAACR; Keith T. Flaherty MD, FAACR;...

Read source
journals.plos.org /1 month ago

A genomic-led strategy to anticipate drug safety effects

by Brian R. Ferolito, Andrea R. V. R. Horimoto, Kai Gravel-Pucillo, Daniel J. Golden, Hesam Dashti, Claudia Giambartolomei, Danielle Rasooly, Rachael Matty, Liam Gaziano, Yakov Tse...

Read source
webwire.com /2 weeks ago

AGC and Neusignal Therapeutics Collaborate on the Development of Alzheimer's Disease Drug Candidate “NTX-083”

AGC Inc. (Headquarters: Tokyo; President: Yoshinori Hirai; hereinafter “AGC”) highlights its end-to-end support capabilities as a small-molecule pharmaceutical CDMO as demonstrated...

Read source
biopharmadive.com /1 month ago

How well are AI-discovered drugs faring in the clinic?

Some of the industry’s most closely-watched AI drugs could provide insight into the success of technology-assisted development.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Drug Discovery.

feeds.feedburner.com

Recent coverage from public sources
Public source

rssfeeds.webwire.com

Recent coverage from public sources
Public source

asiatimes.com

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

e27.co

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source